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Introduction
Hepatocellular carcinoma (HCC) is one of the leading causes for cancer-related death [1] . Although HCC is the sixth most common neoplasm worldwide, poor prognosis makes HCC the third leading cause of cancer-related mortality, responsible for 600,000 deaths annually [2] . In some countries, especially in China, HCC accounted for 70%-85% of primary liver cancer cases [3] , with the burden of disease expected to increase in coming years [4] . Besides multiple genetic and epigenetic changes of protein coding genes in HCC [5] , growing evidence indicates that deregulation of miRNAs can also contribute to HCC development investigations are needed to identify miRNAs which can be employed as prognosis predictor or therapeutic target for HCC.
Previous study had proved that the human cells can be transformed by the cooperation of activated ERK and signaling pathway of PI3K (phosophatidylinositol 3-kinase) [23] . PI3K signaling can be replaced by various kinases, which can render cell tumorigenic. IKBKE (Inhibitor of nuclear factor kappa-B kinase subunit epsilon also known as I-kappa-B kinase patient-derived tumors [23] .
IKBKE, thus we guessed that miR-4458 may play a role in the pathogenesis of HCC. Here, the functions of miR-4458 and its underlying mechanisms in HCC development were investigated. We found that HCC patients with worse prognosis correlated with the lower level of miR-4458 in HCC tissues. Furthermore, the cell growth of HCC cell lines would be suppressed if we restored miR-4458 expression. IKBKE that miR-4458 is a new prognosis predictor for HCC patients and a new potential therapeutic target for HCC. MiR-4458 mimics and miR-4458 antisense oligonucleotides (ASO) were obtained from GenePharma (GenePharma, China). Following the manufacturer's instructions, miRNAs mimics, negative control (NC) were transfected into cells at 50 nM concentration with Lipofectamine® 2000 transfection reagent. 48 IKBKE according to previous paper [23, 34] .
Materials and Methods

Human Tissue Specimens
MTT assay 3 described previously [35, 36] .
an apoptosis detecting kit (Invitrogen, Canada) as described previously [37] . Samples were determined by assay was performed in Huh-7 cells [24] .
4 cells in triplicate in 0.4% (HEK) or 0.3% (HMEC) Noble agar. After 8 weeks of plating, colonies greater than 100 µm in diameter were counted by microscope. Colonies greater than 200 nm in diameter were counted macroscopically 8 weeks after planting [23] .
Statistical analysis t test when only two groups were compared.
IKBKE between matched pairs. Correlation analysis estimated by the Kaplan-Meier method. Statistical analysis was performed using SPSS software (version 16.0). P
Results
patients
with normal liver, miR-4458 expression in HepG2, Hep3B, SMMC-7721 Huh-7 and Chang is lower. (Fig. 1A) . 30 human hepatocellular carcinoma tissues were collected. Expression As miR-4458 expression in L-02 and HepG2 cell lines were higher than other cell lines, we down-regulated the miR-4458 expression by transfection of miR-4458 ASO. We found that miR-4458 ASO transfection down-regulated the miR-4458 level to 40% level of control (Fig. cell proliferation as expected (Fig. 3B) . Next, Cell apoptosis assay showed that miR-4458 ASO inhibited cell apoptosis in L-02 and HepG2 cell lines than control (Fig. 3C) . Similarly, L-02 that, still, miR-4458 ASO inhibited cell apoptosis under the pretreatment of 5-Fu (Fig. 2D) .
found that miR-4458 could bind 11 genes (Fig. 4A) . Of these predicated genes, IKBKE was IKBKE and our interests, IKBKE was chosen for further study.
IKBKE, the putative miR-4458 binding site IKBKE was mutated (Fig. 4B) . A dual luciferase reporter gene assay was performed IKBKE expression in HCC, HCC tissue microarray of 222 patients' expression was higher in HCC tissue increased in 200 of 222 HCC tissues compared with the matched adjacent normal tissues, suggesting that IKBKE may be an important protein associated with the development of IKBKE overexpression in HCC, we investigated whether the levels of IKBKE expression were associated with overall survival in HCC. 222 HCC patients had been followed-up for 3 years. Kaplan-Meier curves indicated that patients with higher IKBKE with lower IKBKE IKBKE, we transfected IKBKE overexpression plasmid into L-02 and HepG2, and found the colony number of tumor cell IKBKE after the miR-4458 transfection, we found that IKBKE over-expression increased the cell numbers, and partly reduced the inhibitory effect of miR-4458 in SMMC-7721 and Huh-7 (Fig. 5E ) Next we down-regulated Informatics prediction showed that NRAS and are the potential targeted genes of miR-4458. Previous study showed that NRAS signaling pathways which play central roles in carcinogenesis of HCC [44] .
in HCC could be targeted by miR-26a which inhibits HCC proliferation [45] . Whether miR-4458 plays its role via NRAS and needed further investigation. HCC is the most fatal cancer around the world, especially in China. HCC confers a poor 4458 showed in our data indicated the therapy drug possibility of miR-4458. Also, viral and nonviral vectors are being developed by delivery of synthetic RNA to liver [46] [47] [48] . Hence, restoration of miR-4458 should have a considerable potential for HCC molecular therapy.
In conclusion, we proved the role of miR-4458 in HCC, and miR-4458 inhibited HCC cell viability via targeting IKBKE. We also highlight IKBKE as a HCC prognosis predictor.
